Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
ACE Inhibitors
16%
Ankle-brachial Index
16%
Antiplatelet Therapy
33%
Cardiovascular Risk
16%
Cardiovascular Risk Markers
16%
Cholesterol
16%
Cigarette Smoking
33%
Claudication
16%
Clinical High Risk
16%
Current Smokers
16%
Evidence-based Treatment
16%
Health Professionals
16%
High Risk
16%
Hypercholesterolemia
16%
Hypertension
33%
Improved Outcomes
16%
Medical Management
33%
Peripheral Arterial Disease
100%
Prospective Registry
100%
Quality of Life
16%
Risk Factors
33%
Smoking Cessation
16%
Statins
33%
Suboptimal Treatment
16%
Systematic Method
16%
Use of Evidence
16%
Vascular Events
16%
Nursing and Health Professions
Ankle Brachial Index
16%
Cardiovascular Risk
33%
Cholesterol Blood Level
16%
Cigarette Filter
33%
Claudication
16%
Dipeptidyl Carboxypeptidase Inhibitor
16%
Disease Management
33%
Health Practitioner
16%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
16%
Hypercholesterolemia
16%
Nicotine Withdrawal
16%
Patient Referral
33%
Peripheral Occlusive Artery Disease
100%
Quality of Life
16%
Statins therapy
16%
Biochemistry, Genetics and Molecular Biology
Awareness
50%
Cholesterol Blood Level
50%
Cigarette Smoking
100%
Hypercholesterolemia
50%
Smoking Cessation
50%
Statin
100%
Medicine and Dentistry
ACE Inhibitor
16%
Ankle Brachial Index
16%
Antiplatelet
33%
Arteriosclerosis Obliterans
100%
Awareness
16%
Cardiovascular Risk
33%
Cigarette Smoking
33%
Claudication
16%
Hypercholesterolemia
16%
Nicotine Withdrawal
16%
Patient Referral
33%
Quality of Life
16%
Statin
33%
Pharmacology, Toxicology and Pharmaceutical Science
Antiplatelet
33%
Cardiovascular Risk
33%
Cigarette Smoking
33%
Claudication
16%
Dipeptidyl Carboxypeptidase Inhibitor
16%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
33%
Hypercholesterolemia
16%
Peripheral Occlusive Artery Disease
100%